SA-7-49

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameSA-7-49
Drug Alias NameSA-7-49
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload
Mechanisms of ActionDNA topoisomerase I inhibitorsAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2DNA topoisomerase I
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghaiTech University
China Registration ClassN/A

Develop Information

Active CompaniesShanghaiTech University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A